进展性家族性肝内胆固醇症 (PFIC) 的免疫组织化学:弥合形态和遗传之间的差距
Neha Nigam1, Chhagan Bihari2, Moinak S Sarma3
1Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Journal of clinical and experimental hepatology
|May 19, 2025
概括
免疫组织化学 (IHC) 能够有效地识别出渐进性家族性肝内胆固醇衰竭 (PFIC) 亚型,并将其与其他小儿胆固醇衰竭原因区分开来. 这种方法为诊断PFIC提供了昂贵的基因分析的可行替代方案.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿科胃肠病学 儿科胃肠病学
- 分子病理学分子病理学
背景情况:
- 渐进性家族性肝内胆固醇症 (PFIC) 涵盖了由胆汁分泌和输送缺陷引起的各种疾病.
- PFIC在其亚型中呈现出各种各样的临床特征,实验室结果,治疗反应和预后.
- 基因分析是PFIC的诊断黄金标准,由于成本和时间的限制,往往无法获得.
研究的目的:
- 评估免疫组织化学 (IHC) 作为PFIC亚型的诊断工具.
- 评估IHC区分PFIC与其他儿科胆固醇病的能力.
- 为了确定特定蛋白质标记物在PFIC亚型化中的有用性.
主要方法:
- 该研究包括40名遗传确认的PFIC患者和20名非PFIC对照.
- 对胆汁盐出口 (BSEP),多药耐药性蛋白3 (MDR3),紧结蛋白2 (TJP2) 和MYO5B进行了免疫组织化学 (IHC).
- 从医院记录中收集了临床数据和实验室发现.
主要成果:
- 针对BSEP,MDR3,TJP2和MYO5B的IHC染色显示了区分PFIC亚型的独特模式.
- 在PFIC和非PFIC组之间观察到BSEP,MDR3和TJP2表达的显著差异 (P <0.05).
- 在使用IHC诊断PFIC 2 (BSEP),PFIC 3 (MDR3),PFIC 4 (TJP2) 和PFIC 6 (MYO5B) 时,获得了高灵敏度和特异性.
结论:
- 针对BSEP,MDR3,TJP2和MYO5B的免疫覆盖有效地区分了PFIC亚型.
- IHC是区分PFIC患者与非PFIC儿科胆固醇病例的一个有价值的工具.
- 这种基于IHC的方法为PFIC诊断提供了切实可行的替代方案.
相关概念视频
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:24Chronic Pancreatitis I: Introduction
906
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
906
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:25Chronic Pancreatitis I: Introduction
26
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26
01:21Chronic Pancreatitis II: Pathophysiology
30
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30